Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabetes Prevention Program
NCT00004992Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jul 1996
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoint: Development of diabetes at 5 years. Started Jul 1996; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00004992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004992.